All In MedTech

FDA Clearance Tracker · P220013-S011

TactiFlex™ Ablation Catheter, Sensor Enabled™

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 5, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 5, 2025

Approved

Time to decision

355 days

Received Mar 15, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P220013-S011
Device name
TactiFlex™ Ablation Catheter, Sensor Enabled™
Applicant location
Plymouth, MN
Received
Mar 15, 2024
Decided
Mar 5, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P220013

Device type

Device class
Class III

Every decision under product code OAE

FDA's approval statement

As written in FDA's record.

to add Midwest Sterilization Corporation (Midwest) as an ethylene oxide (EO) sterilization vendor for the TactiFlex Ablation Catheter at the Midwest Jackson, MO facility.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.